←Back to Expert Scholars
Translational Medicine / 转化医学Drug Repurposing, ReDO Project
Pan Pantziarka
PhD
🏢Anticancer Fund🌐Belgium
Program Director, Drug Repurposing
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Pan Pantziarka leads the ReDO (Repurposing Drugs in Oncology) project cataloging evidence for non-cancer drugs with anticancer potential. His work champions mebendazole, itraconazole, and other generic candidates in oncology. He coordinates repurposing research at the Anticancer Fund.
Share:
🧪Research Fields 研究领域
drug repurposing
ReDO project
off-patent drugs
non-oncology drugs
cancer pharmacology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Pan Pantziarka 的研究动态
Follow Pan Pantziarka's research updates
留下邮箱，当我们发布与 Pan Pantziarka（Anticancer Fund）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment